Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion type Assertion NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_head.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion description "[Liver metastases (n = 93) along with primary tumors (n = 48) were analyzed for K-Ras mutations (codons 12 and 13), p53 mutations (exons 4-9), p53 polymorphism (codon 72), thymidylate synthase (TS) polymorphism (28-bp repeats including G>C mutation), methylenetetrahydrofolate reductase polymorphism (677C>T, 1298A>C), thymidylate synthase (TS) activity, dihydropyrimidine dehydrogenase activity, folylpolyglutamate synthase activity, and p53 protein expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_provenance.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion evidence source_evidence_literature NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_provenance.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion SIO_000772 18676755 NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_provenance.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion wasDerivedFrom befree-20140225 NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_provenance.
- NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_assertion wasGeneratedBy ECO_0000203 NP601917.RAKpsKaRY613HncqYV8OGWf0Ny1r2Nuj-NfJCf--4WcAM130_provenance.